| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000018338 |
| Receipt No. | R000021226 |
| Official scientific title of the study | The influence that visual feedback gives in a knee extension muscular strength level |
| Date of disclosure of the study information | 2016/01/06 |
| Last modified on | 2016/07/27 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The influence that visual feedback gives in a knee extension muscular strength level | |
| Title of the study (Brief title) | The influence that visual feedback gives in a knee extension muscular strength level | |
| Region |
|
|
| Condition | ||
| Condition | stroke and weak elderly person | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Consider whether the knee extension muscular strength of an elderly person and the cerebral damage patient produces a difference by having visual feedback or not. In addition, examine stigmata and the characteristic of the cognitive function to affect the difference of the muscular strength level. |
| Basic objectives2 | Others |
| Basic objectives -Others | Validity, difference |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Isometric knee extension muscular strength level |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | I measure isometric knee extension muscular strength without using visual feedback. | |
| Interventions/Control_2 | I measure isometric knee extension muscular strength using visual feedback. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Our House inpatient whom there is a request of the rehabilitation than a doctor and undergoes rehabilitation with the goal of improvement of the muscular strength and intervenes in.
A stroke patient and a weak elderly patient. The patient whom there is not of science views to suggest a person without the past of a knee joint disease and cancer, a knee joint ache and inflammation of the knee joint such as a feeling of heat, swelling, the flare on carrying out the isometric knee extension muscular strength measurement. The patient whom I can recognize measurements of the muscular strength measuring equipment, and a procedure of the muscular strength measurement can understand. About the recognition of measurements, I show the indication of measurements and judge it whether you can call out time exactly. The patient that an agreement by the free will of a patient or the family was provided after understanding enough after having received enough explanation on participating of the final examination The patient who is stable in its condition of a patien |
|||
| Key exclusion criteria | The patient who is not stable in its condition of a patient
The person that understanding and an agreement are not provided by the person or a family for participation of the final examination The patient whom it was judged an examination responsibility doctor or an examination allotment doctor to be inappropriate as a subject |
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Takuma Mogamiya |
| Organization | Department of Rehabilitation Medicine StMarianna University Yokohama City Seibu Hospital |
| Division name | Rehabilitation part |
| Address | 1197-1, Yasashicho, Asahi-ku, Yokohama-shi, Kanagawa |
| TEL | 045-366-1111 |
| hdmcj204@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Takuma Mogamiya |
| Organization | Department of Rehabilitation Medicine StMarianna University Yokohama City Seibu Hospital |
| Division name | Rehabilitation part |
| Address | 1197-1, Yasashicho, Asahi-ku, Yokohama-shi, Kanagawa |
| TEL | 045-366-1111 |
| Homepage URL | |
| hdmcj204@yahoo.co.jp | |
| Sponsor | |
| Institute | Department of Rehabilitation Medicine StMarianna University Yokohama City Seibu Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Department of Rehabilitation Medicine StMarianna University Yokohama City Seibu Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000021226 |